Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trialXiaotian Zhang, Jiafu Ji, Lianhai Zhang et al.|The Lancet Oncology|2021Cited by 436
A novel 3’tRNA-derived fragment tRF-Val promotes proliferation and inhibits apoptosis by targeting EEF1A1 in gastric cancerHuaiping Cui, Leping Li|Cell Death and Disease|2022Cited by 99
miR‑30 decreases multidrug resistance in human gastric cancer cells by modulating cell autophagyXinming Du, Leping Li|Experimental and Therapeutic Medicine|2017Cited by 64
miR-135b-5p promotes gastric cancer progression by targeting CMTM3Mingdong Lu, Leping Li|International Journal of Oncology|2017Cited by 57
microRNA-20a enhances the epithelial-to-mesenchymal transition of colorectal cancer cells by modulating matrix metalloproteinasesTao Xu, Leping Li|Experimental and Therapeutic Medicine|2015Cited by 50